Natco Pharma, others sued in US for generic cancer drug Ruchika Sharma8 Sept 2023 4:13 PM ISTHyderabad: Natco Pharma on Friday said the company and other drug makers have been named defendants in an antitrust lawsuit regarding a generic...
Shilpa Medicare Psoriatic arthritis drug Apremilast gets USFDA okay Ruchika Sharma11 April 2023 1:00 PM ISTKarnataka: Shilpa Medicare has recently announced that the Company has received final approval from the U.S Food and Drug...
Natco Pharma rolls out additional strengths for generic version of Revlimid in US Ruchika Sharma10 March 2023 2:15 PM ISTLenalidomide capsules are a prescription medicine used in adults for the treatment of multiple myeloma.
Bristol Myers Squibb wins dismissal of USD 6.4 billion lawsuit over cancer drug delay Ruchika Sharma3 March 2023 2:30 PM ISTNew York: A U.S. judge on Wednesday dismissed a lawsuit accusing Bristol Myers Squibb Co of defrauding investors who stood to receive $6.4 billion had...
Sun Pharma bags USFDA okay for generic lenalidomide capsules Ruchika Sharma11 Feb 2023 12:30 PM ISTMumbai: Pharma major, Sun Pharmaceutical Industries Limited, has announced that one of its wholly owned subsidiaries has received final approval from...
Multiple myeloma drug case: Dr Reddy Labs gets legal respite in US Ruchika Sharma29 Dec 2022 4:30 PM ISTNew Delhi: Drugmaker, Dr Reddy's Laboratories has announced that all claims against it in the antitrust litigation filed in the US, related to a...
Shared Monopoly in sale of generic Revlimid: Dr Reddy's Labs, Bristol Myers Squibb and others face anti-trust litigation in US Ruchika Sharma23 Nov 2022 11:52 AM ISTThe company said the complaint "alleges that the challenged agreements improperly delayed generic entry entirely until 2022 and then improperly...
Natco Pharma unveils first generic version of Pomalyst capsules in Australia Ruchika Sharma9 Nov 2022 4:01 PM ISTPomalidomide is prescribed for treatment of Multiple Myeloma and Kaposi Sarcoma.
Dr Reddy's Labs unveils cancer drug Lenalidomide in US Ruchika Sharma8 Sept 2022 2:47 PM ISTDr. Reddy's Lenalidomide Capsules are available in strengths of 2.5 mg, 5 mg, and 10 mg, each in a bottle-count size of 28, as well as 15 mg, 20 mg,...
Cipla Cancer drug Lenalidomide bags USFDA okay Ruchika Sharma7 Sept 2022 4:22 PM ISTMumbai: Drugmaker, Cipla Limited, today announced that the company has received final approval for its Abbreviated New Drug Application (ANDA) for...
Bristol Myers Squibb must face USD 6.4 billion lawsuit over delayed cancer drug Ruchika Sharma25 Jun 2022 3:30 PM ISTThe case arose from the company's agreement to pay Celgene shareholders holding "contingent value rights" an extra $9 per share in cash if it won U.S....
NATCO Announces Launch of the First Generic Version of Revlimid, in the U.S. market MD Bureau8 March 2022 2:50 PM ISTNATCO and Teva are launching these strengths of lenalidomide pursuant to a license of patents owned by Celgene.
